News
Edwards Lifesciences received conditional investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to initiate a clinical trial of its Edwards Sapien 3 transcatheter aortic heart valve and accessories.
August 06, 2013
News
August 5, 2013 — AstraZeneca announced results from a new sub-analysis of the PLATO study that evaluated the incidence of stent thrombosis in patients with acute coronary syndrome (ACS).
August 05, 2013
News
Thubrikar Aortic Valve’s Optimum TAV, transcatheter aortic valve implantation (TAVI) system, has surpassed 200 million cycles in an ongoing durability test — which simulates over five years in humans and meets the requirement set by the International Organization for Standardization (ISO) — in a third party GLP study.
August 05, 2013Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News
Abiomed Inc. reported that physicians have implanted more than 15,000 Impella pumps in U.S. patients requiring hemodynamic support. The 15,000th Impella procedure took place at Mercy General Hospital in Sacramento, Calif., with an Impella pump that provided prophylactic circulatory support.
August 05, 2013Technology
The U.S. Food and Drug Administration (FDA) recently granted market clearance for a hand lotion designed to offer radiation protection from X-rays. Physicians such as interventional cardiologists who work with live angiographic fluoroscopic X-ray systems often have their hands in the radiation field during imaging. The cream, developed by radiation protection product company BloXR Corp., is applied prior to donning gloves, or over a glove with another glove on top, to serve as a lightweight radiation shield
August 02, 2013
News
Abbott announced results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay. The study, conducted by researchers at Brigham and Women's Hospital, demonstrated that Abbott's hsTnI test (currently for research-use only in the United States) may help doctors predict which patients presenting with symptoms of a heart attack, such as severe chest pain, are at a higher risk for having a heart attack 30 days later.
August 02, 2013Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
News
Mercator MedSystems has been issued U.S. Patent 8,465,752, which protects the company’s sole U.S. rights to deliver drugs or other nerve modifying agents to tissue surrounding arteries for renal denervation (RDN). The system also can be used for carotid body modulation (CBM) procedures.
August 02, 2013
News
InspireMD Inc. said the first patient has been enrolled in the Master II IDE clinical trial to evaluate the safety and effectiveness of the MGuard Prime Embolic Protection Stent (EPS) in patients suffering from ST elevation myocardial infarction (STEMI).
August 01, 2013
Technology
The Mikro-Cath disposable blood pressure catheter delivers accurate and reliable hemodynamic data from within the heart or vascular system for expert insight in advanced applications.
August 01, 2013Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
August 1, 2013 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rhythmia mapping system, a next-generation 3-D mapping and navigation solution for use in cardiac catheter ablations and other electrophysiology (EP) procedures to diagnose or treat a variety of conditions in which the heart beats abnormally.
August 01, 2013News
Magnetic resonance imaging (MRI) scans of children who have had chemotherapy can detect early changes in their hearts, according to research findings in BioMed Central's open access journal Journal of Cardiovascular Magnetic Resonance.
July 31, 2013
Technology
Polymer Technology Systems Inc. has introduced the CardioChek Plus analyzer. It is a combination reflectance lipid and electrochemical glucose analyzer that delivers rapid test results for lipids and glucose simultaneously. The system has Wi-Fi capabilities and can transmit patient results to data collection applications.
July 31, 2013Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Feature | Gavin Hays, CEO, Springboard Inc.
The healthcare sector in the United States is facing several reforms, mainly from the implementation of the Patient Protection and Affordable Care Act. However, the results from a survey of 1,710 cath lab clinicians projected a positive outlook for participating clinical professionals with the majority of the respondents reporting higher wages and more than three quarters of the respondents expecting to receive annual salary increases. This indicates that the trend toward higher wages will continue going forward.
July 30, 2013
Feature | Dave Fornell
One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat pharmacologically uncontrolled hypertension. It is estimated there are more than 10 million drug-resistant hypertension patients in the United States, so renal denervation (RDN) may offer a massive new market for cath labs to tap into.
July 30, 2013
Technology
Nick Cavros, interventional cardiologist with Cardiovascular Institute of the South (CIS) at Lafayette General Medical Center in Lafayette, La., used a new hand-held mechanical aspiration system to remove blood clots and increase blood flow.
July 30, 2013© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now